Quick Dispatch:
Your eccogene glp 1 China's Eccogene Inks USD2 Billion Obesity Drug Deal With AstraZeneca orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your eccogene glp 1 China's Eccogene Inks USD2 Billion Obesity Drug Deal With AstraZeneca ships.
Need Help?
Questions about eccogene glp 1 China's Eccogene Inks USD2 Billion Obesity Drug Deal With AstraZeneca, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for eccogene glp 1 China's Eccogene Inks USD2 Billion Obesity Drug Deal With AstraZeneca in your area.
Eccogene obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases
24.31
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism
20.53
GLP-1s: The Second Serving
26.25
GLP-1 and Anesthesia: Considerations and Cautions for CRNAs
23.41
Oral GLP-1 Market to Rise at 35.05% CAGR till 2035
28.19
The Multi-Sector Impacts of GLP-1RA Drugs
22.96
Obesity plus': What's next for GLP-1s?
23.03
